健康眼与青光眼内层视网膜神经元的累积丢失
研究使用自适应光学光学相干断层扫描(AO-OCT)在6名健康人和2名青光眼患者中纵向追踪单个神经节细胞(GC)胞体,健康人平均丢失率为-0.10%/年,一名青光眼患者在弓形缺损区丢失率超过100倍(-31.6%/年),另一名接近正常(-0.26%/年)。
要点
- 健康人GC胞体年丢失率为-0.10%(95%CI -0.09至-0.11%/年),稳定一致。
- 一名青光眼患者弓形缺损区丢失率达-31.6%/年,对应GCL变薄-13%/年。
- AO-OCT可活体追踪单个GC胞体,为纵向评估GC健康提供敏感工具。
核心结论
- 活体测量单个GC胞体丢失可行,能敏感反映健康与青光眼GC的纵向变化。
研究设计与样本
- 对6名健康者和2名青光眼患者用AO-OCT在多个视网膜位置成像,健康者每年一次共4个时间点,青光眼患者基线后2至3年再成像。
主要发现
- 健康者共追踪23,586个胞体,胞体密度与组织学值一致并与GCL厚度强相关(R2=0.96)。
- 健康者平均胞体丢失率为-0.10%/年(95%CI -0.09至-0.11%/年),个体和位置间无显著差异。
- 一名青光眼患者弓形缺损内丢失率为-31.6%/年,另一名接近正常(-0.26%/年)。
临床怎么用
- AO-OCT追踪单个GC胞体可用于青光眼等疾病的纵向GC健康评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Considerable ganglion cell (GC) loss occurs over the normal human lifespan and even more in ocular diseases such as glaucoma. Current clinical methods, however, lack sufficient resolution and sensitivity to directly detect GC loss. Here, we used adaptive optics optical coherence tomography (AO-OCT) to overcome these limitations, enabling longitudinal tracking of individual GC somas and direct measurement of their loss in healthy and glaucomatous eyes. METHODS: Six healthy subjects and two patients with glaucoma were imaged at multiple retinal locations using AO-OCT. Healthy subjects were imaged annually for up to 3 years (4 total timepoints); patients with glaucoma were reimaged 2 to 3 years after baseline. Individual ganglion cell layer (GCL) somas were identified and tracked across sessions and soma densities were quantified. A flicker-based image comparison approach enabled sensitive detection of soma loss from which cumulative loss was determined by subject and location. RESULTS: The GCL soma mosaic was highly stable, with 23,586 somas tracked in healthy subjects. Soma densities agreed with histologic values, including near the fovea, and correlated strongly with GCL thickness (R2 = 0.96). The mean soma loss rate in healthy subjects was -0.10%/year (95% confidence interval [CI] = -0.09 to -0.11%/year), with no significant differences across subjects or locations. By contrast, one glaucoma patient showed a loss rate within an arcuate defect over 100× greater (-31.6%/year; corresponding GCL thinning rate of -13%/year), whereas the other demonstrated a near-normal rate (-0.26%/year). CONCLUSIONS: In vivo measurement of individual GC soma loss is now feasible and provides a sensitive tool for longitudinal evaluation of GC health.
引用
- Kurokawa K, Crowell JA, Liu Y, et al. Cumulative Loss of Inner Retinal Neurons in Healthy and Glaucoma Subjects. Invest Ophthalmol Vis Sci. 2026. PMID: 42695761. doi:10.1167/iovs.67.11.10
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。